A61K 31/382
Having six-membered rings
Official title: having six-membered rings, e.g. thioxanthenes (thiothixene A61K31/496)
A61K31/382 (Having six-membered rings) appears on 298 US grants and 526 published applications in this corpus.
Search patents in A61K- Granted patents
- 298
- Published applications
- 526
- Assignees
- 307
- Inventors
- 1,058
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 6 | 0 |
| 1998 | 2 | 0 |
| 1999 | 7 | 0 |
| 2000 | 8 | 0 |
| 2001 | 10 | 1 |
| 2002 | 8 | 12 |
| 2003 | 4 | 12 |
| 2004 | 4 | 20 |
| 2005 | 2 | 21 |
| 2006 | 3 | 13 |
| 2007 | 2 | 10 |
| 2008 | 2 | 10 |
| 2009 | 4 | 13 |
| 2010 | 3 | 11 |
| 2011 | 7 | 25 |
| 2012 | 6 | 22 |
| 2013 | 11 | 18 |
| 2014 | 18 | 29 |
| 2015 | 16 | 23 |
| 2016 | 20 | 31 |
| 2017 | 20 | 28 |
| 2018 | 22 | 32 |
| 2019 | 27 | 25 |
| 2020 | 17 | 30 |
| 2021 | 14 | 19 |
| 2022 | 11 | 24 |
| 2023 | 8 | 28 |
| 2024 | 13 | 32 |
| 2025 | 9 | 17 |
| 2026 | 9 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Compositions for the treatment of hypertension7 Jul 2026US 12,673,047 B2The George Institute for Global Health
- Methods for improving renal function with a combination of a bet bromodomain inhibitor and a sodium dependent glucose transport 2 inhibitor7 Jul 2026US 12,673,059 B2Resverlogix Corp.
- Compositions for the treatment of hypertension23 Jun 2026US 12,661,345 B2The George Institute for Global Health
- Small molecule inhibitors of autophagy and histone deactylases and uses thereof19 May 2026US 12,629,362 B2Arizona Board of Regents on Behalf of the University of Arizona
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Compositions for the treatment of hypertension24 Sep 2026US 2026/0284022 A1The George Institute for Global Health
- Epoxy compound and use thereof10 Sep 2026US 2026/0265270 A1Shanghai Huilun Pharmaceutical Co., Ltd.
- Compositions for the treatment of hypertension3 Sep 2026US 2026/0256754 A1The George Institute for Global Health
- Use of nitrone compounds or pharmaceutically acceptable salts thereof in combination with sglt-2 inhibitors20 Aug 2026US 2026/0240838 A1Guangzhou Magpie Pharmaceuticals Co., Ltd.
Most cited
By later US patents
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Small molecule toll-like receptor (TLR) antagonists91US 7,410,975 B2Coley Pharmaceutical GmbH · 2008
- Retinoid inhibition of expression of VEGF80US 6,001,885 ACentre International de Recherches Dermatologiques · 1999
- Sulfide and disulfide compounds and compositions for cholesterol management and related uses68US 6,703,422 B2Esperion Therapeutics, Inc. · 2004
- Male anti-fertility agents60US 6,521,641 B1Allergan, Inc. · 2003